-
1
-
-
77958071837
-
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study
-
Alves G., Bronnick K., Aarsland D., Blennow K., Zetterberg H., Ballard C., Kurz M.W., Andreasson U., Tysnes O.B., Larsen J.P., Mulugeta E. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry 2010, 81:1080-1086.
-
(2010)
J. Neurol. Neurosurg. Psychiatry
, vol.81
, pp. 1080-1086
-
-
Alves, G.1
Bronnick, K.2
Aarsland, D.3
Blennow, K.4
Zetterberg, H.5
Ballard, C.6
Kurz, M.W.7
Andreasson, U.8
Tysnes, O.B.9
Larsen, J.P.10
Mulugeta, E.11
-
2
-
-
0142250857
-
Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates
-
Baulac S., Lavoie M.J., Kimberly W.T., Strahle J., Wolfe M.S., Selkoe D.J., Xia W. Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol. Dis 2003, 14:194-204.
-
(2003)
Neurobiol. Dis
, vol.14
, pp. 194-204
-
-
Baulac, S.1
Lavoie, M.J.2
Kimberly, W.T.3
Strahle, J.4
Wolfe, M.S.5
Selkoe, D.J.6
Xia, W.7
-
3
-
-
47849090167
-
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels
-
Bekris L.M., Millard S.P., Galloway N.M., Vuletic S., Albers J.J., Li G., Galasko D.R., Decarli C., Farlow M.R., Clark C.M., Quinn J.F., Kaye J.A., Schellenberg G.D., Tsuang D., Peskind E.R., Yu C.E. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J. Alzheimers Dis 2008, 13:255-266.
-
(2008)
J. Alzheimers Dis
, vol.13
, pp. 255-266
-
-
Bekris, L.M.1
Millard, S.P.2
Galloway, N.M.3
Vuletic, S.4
Albers, J.J.5
Li, G.6
Galasko, D.R.7
Decarli, C.8
Farlow, M.R.9
Clark, C.M.10
Quinn, J.F.11
Kaye, J.A.12
Schellenberg, G.D.13
Tsuang, D.14
Peskind, E.R.15
Yu, C.E.16
-
4
-
-
77952889956
-
CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models
-
Benito E., Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci 2010, 33:230-240.
-
(2010)
Trends Neurosci
, vol.33
, pp. 230-240
-
-
Benito, E.1
Barco, A.2
-
5
-
-
79952899744
-
Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer Disease
-
Cai G., Atzmon G., Naj A.C., Beecham G.W., Barzilai N., Haines J.L., Sano M., Pericak-Vance M., Buxbaum J.D. Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer Disease. Neurobiol. Aging 2010, 2010.
-
(2010)
Neurobiol. Aging
, vol.2010
-
-
Cai, G.1
Atzmon, G.2
Naj, A.C.3
Beecham, G.W.4
Barzilai, N.5
Haines, J.L.6
Sano, M.7
Pericak-Vance, M.8
Buxbaum, J.D.9
-
6
-
-
0036042518
-
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients
-
Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., Di Luca M. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med 2002, 8:67-74.
-
(2002)
Mol. Med
, vol.8
, pp. 67-74
-
-
Colciaghi, F.1
Borroni, B.2
Pastorino, L.3
Marcello, E.4
Zimmermann, M.5
Cattabeni, F.6
Padovani, A.7
Di Luca, M.8
-
7
-
-
42149110867
-
Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17
-
Deuss M., Reiss K., Hartmann D. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr. Alzheimer Res 2008, 5:187-201.
-
(2008)
Curr. Alzheimer Res
, vol.5
, pp. 187-201
-
-
Deuss, M.1
Reiss, K.2
Hartmann, D.3
-
8
-
-
46749142660
-
Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease?. A systematic review and meta-analysis of the literature
-
Diniz B.S., Pinto Junior J.A., Forlenza O.V. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease?. A systematic review and meta-analysis of the literature. World J. Biol. Psychiatry 2008, 9:172-182.
-
(2008)
World J. Biol. Psychiatry
, vol.9
, pp. 172-182
-
-
Diniz, B.S.1
Pinto Junior, J.A.2
Forlenza, O.V.3
-
9
-
-
3042688916
-
S100 proteins in the epidermis
-
Eckert R.L., Broome A.M., Ruse M., Robinson N., Ryan D., Lee K. S100 proteins in the epidermis. J. Invest. Dermatol 2004, 123:23-33.
-
(2004)
J. Invest. Dermatol
, vol.123
, pp. 23-33
-
-
Eckert, R.L.1
Broome, A.M.2
Ruse, M.3
Robinson, N.4
Ryan, D.5
Lee, K.6
-
10
-
-
70349783752
-
Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo
-
Endres K., Mitteregger G., Kojro E., Kretzschmar H., Fahrenholz F. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol. Dis 2009, 36:233-241.
-
(2009)
Neurobiol. Dis
, vol.36
, pp. 233-241
-
-
Endres, K.1
Mitteregger, G.2
Kojro, E.3
Kretzschmar, H.4
Fahrenholz, F.5
-
11
-
-
35648938247
-
Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome
-
Englund H., Anneren G., Gustafsson J., Wester U., Wiltfang J., Lannfelt L., Blennow K., Hoglund K. Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome. Dement. Geriatr. Cogn. Disord 2007, 24:369-374.
-
(2007)
Dement. Geriatr. Cogn. Disord
, vol.24
, pp. 369-374
-
-
Englund, H.1
Anneren, G.2
Gustafsson, J.3
Wester, U.4
Wiltfang, J.5
Lannfelt, L.6
Blennow, K.7
Hoglund, K.8
-
12
-
-
44949221768
-
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
-
Ewers M., Zhong Z., Burger K., Wallin A., Blennow K., Teipel S.J., Shen Y., Hampel H. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Brain 2008, 131:1252-1258.
-
(2008)
Brain
, vol.131
, pp. 1252-1258
-
-
Ewers, M.1
Zhong, Z.2
Burger, K.3
Wallin, A.4
Blennow, K.5
Teipel, S.J.6
Shen, Y.7
Hampel, H.8
-
13
-
-
33644832047
-
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans
-
Fagan A.M., Mintun M.A., Mach R.H., Lee S.Y., Dence C.S., Shah A.R., Larossa G.N., Spinner M.L., Klunk W.E., Mathis C.A., Dekosky S.T., Morris J.C., Holtzman D.M. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol 2006, 59:512-519.
-
(2006)
Ann. Neurol
, vol.59
, pp. 512-519
-
-
Fagan, A.M.1
Mintun, M.A.2
Mach, R.H.3
Lee, S.Y.4
Dence, C.S.5
Shah, A.R.6
Larossa, G.N.7
Spinner, M.L.8
Klunk, W.E.9
Mathis, C.A.10
Dekosky, S.T.11
Morris, J.C.12
Holtzman, D.M.13
-
14
-
-
0026744058
-
Low cerebrospinal fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease
-
Farlow M., Ghetti B., Benson M.D., Farrow J.S., Van Nostrand W.E., Wagner S.L. Low cerebrospinal fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Lancet 1992, 340:453-454.
-
(1992)
Lancet
, vol.340
, pp. 453-454
-
-
Farlow, M.1
Ghetti, B.2
Benson, M.D.3
Farrow, J.S.4
Van Nostrand, W.E.5
Wagner, S.L.6
-
15
-
-
18444417998
-
Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation
-
Francis R., Mcgrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., Curtis D. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 2002, 3:85-97.
-
(2002)
Dev. Cell
, vol.3
, pp. 85-97
-
-
Francis, R.1
Mcgrath, G.2
Zhang, J.3
Ruddy, D.A.4
Sym, M.5
Apfeld, J.6
Nicoll, M.7
Maxwell, M.8
Hai, B.9
Ellis, M.C.10
Parks, A.L.11
Xu, W.12
Li, J.13
Gurney, M.14
Myers, R.L.15
Himes, C.S.16
Hiebsch, R.17
Ruble, C.18
Nye, J.S.19
Curtis, D.20
more..
-
16
-
-
15644363081
-
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
-
Galasko D., Chang L., Motter R., Clark C.M., Kaye J., Knopman D., Thomas R., Kholodenko D., Schenk D., Lieberburg I., Miller B., Green R., Basherad R., Kertiles L., Boss M.A., Seubert P. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch. Neurol 1998, 55:937-945.
-
(1998)
Arch. Neurol
, vol.55
, pp. 937-945
-
-
Galasko, D.1
Chang, L.2
Motter, R.3
Clark, C.M.4
Kaye, J.5
Knopman, D.6
Thomas, R.7
Kholodenko, D.8
Schenk, D.9
Lieberburg, I.10
Miller, B.11
Green, R.12
Basherad, R.13
Kertiles, L.14
Boss, M.A.15
Seubert, P.16
-
17
-
-
0024496624
-
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques
-
Giaccone G., Tagliavini F., Linoli G., Bouras C., Frigerio L., Frangione B., Bugiani O. Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci. Lett 1989, 97:232-238.
-
(1989)
Neurosci. Lett
, vol.97
, pp. 232-238
-
-
Giaccone, G.1
Tagliavini, F.2
Linoli, G.3
Bouras, C.4
Frigerio, L.5
Frangione, B.6
Bugiani, O.7
-
18
-
-
84880187571
-
Tau protein, the paired helical filament and Alzheimer's disease
-
Goedert M., Klug A., Crowther R.A. Tau protein, the paired helical filament and Alzheimer's disease. J. Alzheimers Dis 2006, 9:195-207.
-
(2006)
J. Alzheimers Dis
, vol.9
, pp. 195-207
-
-
Goedert, M.1
Klug, A.2
Crowther, R.A.3
-
19
-
-
33750705653
-
A century of Alzheimer's disease
-
Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
-
(2006)
Science
, vol.314
, pp. 777-781
-
-
Goedert, M.1
Spillantini, M.G.2
-
20
-
-
85047694516
-
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
-
Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest 2004, 114:1624-1634.
-
(2004)
J. Clin. Invest
, vol.114
, pp. 1624-1634
-
-
Gong, B.1
Vitolo, O.V.2
Trinchese, F.3
Liu, S.4
Shelanski, M.5
Arancio, O.6
-
21
-
-
33947492770
-
Variations in the APP gene promoter region and risk of Alzheimer disease
-
Guyant-Marechal L., Rovelet-Lecrux A., Goumidi L., Cousin E., Hannequin D., Raux G., Penet C., Ricard S., Mace S., Amouyel P., Deleuze J.F., Frebourg T., Brice A., Lambert J.C., Campion D. Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology 2007, 68:684-687.
-
(2007)
Neurology
, vol.68
, pp. 684-687
-
-
Guyant-Marechal, L.1
Rovelet-Lecrux, A.2
Goumidi, L.3
Cousin, E.4
Hannequin, D.5
Raux, G.6
Penet, C.7
Ricard, S.8
Mace, S.9
Amouyel, P.10
Deleuze, J.F.11
Frebourg, T.12
Brice, A.13
Lambert, J.C.14
Campion, D.15
-
22
-
-
38049179307
-
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
-
Hampel H., Burger K., Teipel S.J., Bokde A.L., Zetterberg H., Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008, 4:38-48.
-
(2008)
Alzheimers Dement.
, vol.4
, pp. 38-48
-
-
Hampel, H.1
Burger, K.2
Teipel, S.J.3
Bokde, A.L.4
Zetterberg, H.5
Blennow, K.6
-
23
-
-
3142743789
-
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
-
Hampel H., Teipel S.J., Fuchsberger T., Andreasen N., Wiltfang J., Otto M., Shen Y., Dodel R., Du Y., Farlow M., Moller H.J., Blennow K., Buerger K. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol. Psychiatry 2004, 9:705-710.
-
(2004)
Mol. Psychiatry
, vol.9
, pp. 705-710
-
-
Hampel, H.1
Teipel, S.J.2
Fuchsberger, T.3
Andreasen, N.4
Wiltfang, J.5
Otto, M.6
Shen, Y.7
Dodel, R.8
Du, Y.9
Farlow, M.10
Moller, H.J.11
Blennow, K.12
Buerger, K.13
-
24
-
-
0002294347
-
A simple sequential rejective multiple test procedure
-
Holm S. A simple sequential rejective multiple test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
-
(1979)
Scandinavian Journal of Statistics
, vol.6
, pp. 65-70
-
-
Holm, S.1
-
25
-
-
77950613181
-
The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex
-
Jorissen E., Prox J., Bernreuther C., Weber S., Schwanbeck R., Serneels L., Snellinx A., Craessaerts K., Thathiah A., Tesseur I., Bartsch U., Weskamp G., Blobel C.P., Glatzel M., De Strooper B., Saftig P. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci 2010, 30:4833-4844.
-
(2010)
J. Neurosci
, vol.30
, pp. 4833-4844
-
-
Jorissen, E.1
Prox, J.2
Bernreuther, C.3
Weber, S.4
Schwanbeck, R.5
Serneels, L.6
Snellinx, A.7
Craessaerts, K.8
Thathiah, A.9
Tesseur, I.10
Bartsch, U.11
Weskamp, G.12
Blobel, C.P.13
Glatzel, M.14
De Strooper, B.15
Saftig, P.16
-
26
-
-
70349569016
-
Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity
-
Kim M., Suh J., Romano D., Truong M.H., Mullin K., Hooli B., Norton D., Tesco G., Elliott K., Wagner S.L., Moir R.D., Becker K.D., Tanzi R.E. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet 2009, 18:3987-3996.
-
(2009)
Hum. Mol. Genet
, vol.18
, pp. 3987-3996
-
-
Kim, M.1
Suh, J.2
Romano, D.3
Truong, M.H.4
Mullin, K.5
Hooli, B.6
Norton, D.7
Tesco, G.8
Elliott, K.9
Wagner, S.L.10
Moir, R.D.11
Becker, K.D.12
Tanzi, R.E.13
-
27
-
-
0038652102
-
Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2
-
Kimberly W.T., Lavoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S., Selkoe D.J. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. USA 2003, 100:6382-6387.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 6382-6387
-
-
Kimberly, W.T.1
Lavoie, M.J.2
Ostaszewski, B.L.3
Ye, W.4
Wolfe, M.S.5
Selkoe, D.J.6
-
28
-
-
77952337371
-
Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region
-
Lammich S., Buell D., Zilow S., Ludwig A.K., Nuscher B., Lichtenthaler S.F., Prinzen C., Fahrenholz F., Haass C. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. J. Biol. Chem 2010, 285:15753-15760.
-
(2010)
J. Biol. Chem
, vol.285
, pp. 15753-15760
-
-
Lammich, S.1
Buell, D.2
Zilow, S.3
Ludwig, A.K.4
Nuscher, B.5
Lichtenthaler, S.F.6
Prinzen, C.7
Fahrenholz, F.8
Haass, C.9
-
29
-
-
0033616716
-
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
-
Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 1999, 96:3922-3927.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 3922-3927
-
-
Lammich, S.1
Kojro, E.2
Postina, R.3
Gilbert, S.4
Pfeiffer, R.5
Jasionowski, M.6
Haass, C.7
Fahrenholz, F.8
-
30
-
-
10744223903
-
A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex
-
Lee S.F., Shah S., Yu C., Wigley W.C., Li H., Lim M., Pedersen K., Han W., Thomas P., Lundkvist J., Hao Y.H., Yu G. A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex. J. Biol. Chem 2004, 279:4144-4152.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 4144-4152
-
-
Lee, S.F.1
Shah, S.2
Yu, C.3
Wigley, W.C.4
Li, H.5
Lim, M.6
Pedersen, K.7
Han, W.8
Thomas, P.9
Lundkvist, J.10
Hao, Y.H.11
Yu, G.12
-
31
-
-
0030007964
-
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation
-
Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis 1996, 3:16-32.
-
(1996)
Neurobiol. Dis
, vol.3
, pp. 16-32
-
-
Lemere, C.A.1
Blusztajn, J.K.2
Yamaguchi, H.3
Wisniewski, T.4
Saido, T.C.5
Selkoe, D.J.6
-
32
-
-
37549040895
-
Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease
-
Jia and Jia
-
Lv H. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease. Neurobiology of Aging 2008, 29:194-202. Jia and Jia.
-
(2008)
Neurobiology of Aging
, vol.29
, pp. 194-202
-
-
Lv, H.1
-
33
-
-
35448930622
-
Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models
-
Ma Q.L., Harris-White M.E., Ubeda O.J., Simmons M., Beech W., Lim G.P., Teter B., Frautschy S.A., Cole G.M. Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. J. Neurochem 2007, 103:1594-1607.
-
(2007)
J. Neurochem
, vol.103
, pp. 1594-1607
-
-
Ma, Q.L.1
Harris-White, M.E.2
Ubeda, O.J.3
Simmons, M.4
Beech, W.5
Lim, G.P.6
Teter, B.7
Frautschy, S.A.8
Cole, G.M.9
-
34
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
Mckhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
Mckhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
35
-
-
78349237282
-
CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment
-
Montine T.J., Shi M., Quinn J.F., Peskind E.R., Craft S., Ginghina C., Chung K.A., Kim H., Galasko D.R., Jankovic J., Zabetian C.P., Leverenz J.B., Zhang J. CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment. Mov. Disord. 2010, 2010.
-
(2010)
Mov. Disord.
, vol.2010
-
-
Montine, T.J.1
Shi, M.2
Quinn, J.F.3
Peskind, E.R.4
Craft, S.5
Ginghina, C.6
Chung, K.A.7
Kim, H.8
Galasko, D.R.9
Jankovic, J.10
Zabetian, C.P.11
Leverenz, J.B.12
Zhang, J.13
-
36
-
-
0028982454
-
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
-
Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol 1995, 38:643-648.
-
(1995)
Ann. Neurol
, vol.38
, pp. 643-648
-
-
Motter, R.1
Vigo-Pelfrey, C.2
Kholodenko, D.3
Barbour, R.4
Johnson-Wood, K.5
Galasko, D.6
Chang, L.7
Miller, B.8
Clark, C.9
Green, R.10
-
37
-
-
0027994773
-
Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease
-
Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T.T., Shaffer L.M., Golde T.E., Younkin L.H., Younkin S.G. Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann. Neurol 1994, 36:903-911.
-
(1994)
Ann. Neurol
, vol.36
, pp. 903-911
-
-
Nakamura, T.1
Shoji, M.2
Harigaya, Y.3
Watanabe, M.4
Hosoda, K.5
Cheung, T.T.6
Shaffer, L.M.7
Golde, T.E.8
Younkin, L.H.9
Younkin, S.G.10
-
38
-
-
0041886881
-
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
-
Olsson A., Hoglund K., Sjogren M., Andreasen N., Minthon L., Lannfelt L., Buerger K., Moller H.J., Hampel H., Davidsson P., Blennow K. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp. Neurol 2003, 183:74-80.
-
(2003)
Exp. Neurol
, vol.183
, pp. 74-80
-
-
Olsson, A.1
Hoglund, K.2
Sjogren, M.3
Andreasen, N.4
Minthon, L.5
Lannfelt, L.6
Buerger, K.7
Moller, H.J.8
Hampel, H.9
Davidsson, P.10
Blennow, K.11
-
39
-
-
0025302430
-
Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease
-
Palmert M.R., Usiak M., Mayeux R., Raskind M., Tourtellotte W.W., Younkin S.G. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 1990, 40:1028-1034.
-
(1990)
Neurology
, vol.40
, pp. 1028-1034
-
-
Palmert, M.R.1
Usiak, M.2
Mayeux, R.3
Raskind, M.4
Tourtellotte, W.W.5
Younkin, S.G.6
-
40
-
-
0034813578
-
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease
-
Peskind E.R., Griffin W.S., Akama K.T., Raskind M.A., Van Eldik L.J. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem. Int 2001, 39:409-413.
-
(2001)
Neurochem. Int
, vol.39
, pp. 409-413
-
-
Peskind, E.R.1
Griffin, W.S.2
Akama, K.T.3
Raskind, M.A.4
Van Eldik, L.J.5
-
41
-
-
33745828142
-
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition
-
Peskind E.R., Li G., Shofer J., Quinn J.F., Kaye J.A., Clark C.M., Farlow M.R., Decarli C., Raskind M.A., Schellenberg G.D., Lee V.M., Galasko D.R. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch. Neurol 2006, 63:936-939.
-
(2006)
Arch. Neurol
, vol.63
, pp. 936-939
-
-
Peskind, E.R.1
Li, G.2
Shofer, J.3
Quinn, J.F.4
Kaye, J.A.5
Clark, C.M.6
Farlow, M.R.7
Decarli, C.8
Raskind, M.A.9
Schellenberg, G.D.10
Lee, V.M.11
Galasko, D.R.12
-
42
-
-
33644982566
-
Safety and acceptability of the research lumbar puncture
-
Peskind E.R., Riekse R., Quinn J.F., Kaye J., Clark C.M., Farlow M.R., Decarli C., Chabal C., Vavrek D., Raskind M.A., Galasko D. Safety and acceptability of the research lumbar puncture. Alzheimer Dis. Assoc. Disord 2005, 19:220-225.
-
(2005)
Alzheimer Dis. Assoc. Disord
, vol.19
, pp. 220-225
-
-
Peskind, E.R.1
Riekse, R.2
Quinn, J.F.3
Kaye, J.4
Clark, C.M.5
Farlow, M.R.6
Decarli, C.7
Chabal, C.8
Vavrek, D.9
Raskind, M.A.10
Galasko, D.11
-
43
-
-
0032988610
-
Mild cognitive impairment: clinical characterization and outcome
-
Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol 1999, 56:303-308.
-
(1999)
Arch. Neurol
, vol.56
, pp. 303-308
-
-
Petersen, R.C.1
Smith, G.E.2
Waring, S.C.3
Ivnik, R.J.4
Tangalos, E.G.5
Kokmen, E.6
-
44
-
-
42149165496
-
A closer look at alpha-secretase
-
Postina R. A closer look at alpha-secretase. Curr. Alzheimer Res 2008, 5:179-186.
-
(2008)
Curr. Alzheimer Res
, vol.5
, pp. 179-186
-
-
Postina, R.1
-
45
-
-
85047690140
-
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
-
Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., Van Leuven F., Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest 2004, 113:1456-1464.
-
(2004)
J. Clin. Invest
, vol.113
, pp. 1456-1464
-
-
Postina, R.1
Schroeder, A.2
Dewachter, I.3
Bohl, J.4
Schmitt, U.5
Kojro, E.6
Prinzen, C.7
Endres, K.8
Hiemke, C.9
Blessing, M.10
Flamez, P.11
Dequenne, A.12
Godaux, E.13
Van Leuven, F.14
Fahrenholz, F.15
-
46
-
-
33746233383
-
Synapse formation and function is modulated by the amyloid precursor protein
-
Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H.A., Herms J. Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci 2006, 26:7212-7221.
-
(2006)
J. Neurosci
, vol.26
, pp. 7212-7221
-
-
Priller, C.1
Bauer, T.2
Mitteregger, G.3
Krebs, B.4
Kretzschmar, H.A.5
Herms, J.6
-
47
-
-
24644483112
-
Genomic structure and functional characterization of the human ADAM10 promoter
-
Prinzen C., Muller U., Endres K., Fahrenholz F., Postina R. Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J. 2005, 19:1522-1524.
-
(2005)
FASEB J.
, vol.19
, pp. 1522-1524
-
-
Prinzen, C.1
Muller, U.2
Endres, K.3
Fahrenholz, F.4
Postina, R.5
-
48
-
-
2542454942
-
Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex
-
Prokop S., Shirotani K., Edbauer D., Haass C., Steiner H. Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J. Biol. Chem 2004, 279:23255-23261.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 23255-23261
-
-
Prokop, S.1
Shirotani, K.2
Edbauer, D.3
Haass, C.4
Steiner, H.5
-
49
-
-
58449133739
-
S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10
-
Qin W., Ho L., Wang J., Peskind E., Pasinetti G.M. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoS ONE 2009, 4:e4183.
-
(2009)
PLoS ONE
, vol.4
-
-
Qin, W.1
Ho, L.2
Wang, J.3
Peskind, E.4
Pasinetti, G.M.5
-
50
-
-
75549091651
-
ENCODE whole-genome data in the UCSC Genome Browser
-
Rosenbloom K.R., Dreszer T.R., Pheasant M., Barber G.P., Meyer L.R., Pohl A., Raney B.J., Wang T., Hinrichs A.S., Zweig A.S., Fujita P.A., Learned K., Rhead B., Smith K.E., Kuhn R.M., Karolchik D., Haussler D., Kent W.J. ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res. 2010, 38:D620-D625.
-
(2010)
Nucleic Acids Res.
, vol.38
-
-
Rosenbloom, K.R.1
Dreszer, T.R.2
Pheasant, M.3
Barber, G.P.4
Meyer, L.R.5
Pohl, A.6
Raney, B.J.7
Wang, T.8
Hinrichs, A.S.9
Zweig, A.S.10
Fujita, P.A.11
Learned, K.12
Rhead, B.13
Smith, K.E.14
Kuhn, R.M.15
Karolchik, D.16
Haussler, D.17
Kent, W.J.18
-
51
-
-
77249122985
-
Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus
-
Satoh J., Tabunoki H., Arima K. Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis. Markers 2009, 27:239-252.
-
(2009)
Dis. Markers
, vol.27
, pp. 239-252
-
-
Satoh, J.1
Tabunoki, H.2
Arima, K.3
-
52
-
-
16044373524
-
Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
-
Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med 1996, 2:864-870.
-
(1996)
Nat. Med
, vol.2
, pp. 864-870
-
-
Scheuner, D.1
Eckman, C.2
Jensen, M.3
Song, X.4
Citron, M.5
Suzuki, N.6
Bird, T.D.7
Hardy, J.8
Hutton, M.9
Kukull, W.10
Larson, E.11
Levy-Lahad, E.12
Viitanen, M.13
Peskind, E.14
Poorkaj, P.15
Schellenberg, G.16
Tanzi, R.17
Wasco, W.18
Lannfelt, L.19
Selkoe, D.20
Younkin, S.21
more..
-
53
-
-
60349122253
-
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease
-
Schroeder A., Fahrenholz F., Schmitt U. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease. J. Alzheimers Dis 2009, 16:309-314.
-
(2009)
J. Alzheimers Dis
, vol.16
, pp. 309-314
-
-
Schroeder, A.1
Fahrenholz, F.2
Schmitt, U.3
-
54
-
-
0026646605
-
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
-
Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992, 359:325-327.
-
(1992)
Nature
, vol.359
, pp. 325-327
-
-
Seubert, P.1
Vigo-Pelfrey, C.2
Esch, F.3
Lee, M.4
Dovey, H.5
Davis, D.6
Sinha, S.7
Schlossmacher, M.8
Whaley, J.9
Swindlehurst, C.10
-
55
-
-
65249159879
-
Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects
-
Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V.M., Trojanowski J.Q. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann. Neurol 2009, 65:403-413.
-
(2009)
Ann. Neurol
, vol.65
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
Blennow, K.7
Soares, H.8
Simon, A.9
Lewczuk, P.10
Dean, R.11
Siemers, E.12
Potter, W.13
Lee, V.M.14
Trojanowski, J.Q.15
-
56
-
-
4744375540
-
Identification of distinct gamma-secretase complexes with different APH-1 variants
-
Shirotani K., Edbauer D., Prokop S., Haass C., Steiner H. Identification of distinct gamma-secretase complexes with different APH-1 variants. J. Biol. Chem 2004, 279:41340-41345.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 41340-41345
-
-
Shirotani, K.1
Edbauer, D.2
Prokop, S.3
Haass, C.4
Steiner, H.5
-
57
-
-
77957220702
-
CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease
-
Siderowf A., Xie S.X., Hurtig H., Weintraub D., Duda J., Chen-Plotkin A., Shaw L.M., Van Deerlin V., Trojanowski J.Q., Clark C. CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology 2010, 75:1055-1061.
-
(2010)
Neurology
, vol.75
, pp. 1055-1061
-
-
Siderowf, A.1
Xie, S.X.2
Hurtig, H.3
Weintraub, D.4
Duda, J.5
Chen-Plotkin, A.6
Shaw, L.M.7
Van Deerlin, V.8
Trojanowski, J.Q.9
Clark, C.10
-
58
-
-
34250847115
-
The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain
-
Stockley J.H., O'Neill C. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Biochem. Soc. Trans 2007, 35:574-576.
-
(2007)
Biochem. Soc. Trans
, vol.35
, pp. 574-576
-
-
Stockley, J.H.1
O'Neill, C.2
-
59
-
-
20944444583
-
Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes
-
Sun X., Wang Y., Qing H., Christensen M.A., Liu Y., Zhou W., Tong Y., Xiao C., Huang Y., Zhang S., Liu X., Song W. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J. 2005, 19:739-749.
-
(2005)
FASEB J.
, vol.19
, pp. 739-749
-
-
Sun, X.1
Wang, Y.2
Qing, H.3
Christensen, M.A.4
Liu, Y.5
Zhou, W.6
Tong, Y.7
Xiao, C.8
Huang, Y.9
Zhang, S.10
Liu, X.11
Song, W.12
-
60
-
-
0037514257
-
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
-
Sunderland T., Linker G., Mirza N., Putnam K.T., Friedman D.L., Kimmel L.H., Bergeson J., Manetti G.J., Zimmermann M., Tang B., Bartko J.J., Cohen R.M. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003, 289:2094-2103.
-
(2003)
JAMA
, vol.289
, pp. 2094-2103
-
-
Sunderland, T.1
Linker, G.2
Mirza, N.3
Putnam, K.T.4
Friedman, D.L.5
Kimmel, L.H.6
Bergeson, J.7
Manetti, G.J.8
Zimmermann, M.9
Tang, B.10
Bartko, J.J.11
Cohen, R.M.12
-
61
-
-
7444271086
-
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele
-
Sunderland T., Mirza N., Putnam K.T., Linker G., Bhupali D., Durham R., Soares H., Kimmel L., Friedman D., Bergeson J., Csako G., Levy J.A., Bartko J.J., Cohen R.M. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol. Psychiatry 2004, 56:670-676.
-
(2004)
Biol. Psychiatry
, vol.56
, pp. 670-676
-
-
Sunderland, T.1
Mirza, N.2
Putnam, K.T.3
Linker, G.4
Bhupali, D.5
Durham, R.6
Soares, H.7
Kimmel, L.8
Friedman, D.9
Bergeson, J.10
Csako, G.11
Levy, J.A.12
Bartko, J.J.13
Cohen, R.M.14
-
62
-
-
62449262536
-
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
-
Tapiola T., Alafuzoff I., Herukka S.K., Parkkinen L., Hartikainen P., Soininen H., Pirttila T. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol 2009, 66:382-389.
-
(2009)
Arch. Neurol
, vol.66
, pp. 382-389
-
-
Tapiola, T.1
Alafuzoff, I.2
Herukka, S.K.3
Parkkinen, L.4
Hartikainen, P.5
Soininen, H.6
Pirttila, T.7
-
63
-
-
69249128689
-
Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein
-
Taylor D.R., Parkin E.T., Cocklin S.L., Ault J.R., Ashcroft A.E., Turner A.J., Hooper N.M. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J. Biol. Chem 2009, 284:22590-22600.
-
(2009)
J. Biol. Chem
, vol.284
, pp. 22590-22600
-
-
Taylor, D.R.1
Parkin, E.T.2
Cocklin, S.L.3
Ault, J.R.4
Ashcroft, A.E.5
Turner, A.J.6
Hooper, N.M.7
-
64
-
-
0034639656
-
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
-
Theuns J., Del-Favero J., Dermaut B., Van Duijn C.M., Backhovens H., Van Den Broeck M.V., Serneels S., Corsmit E., Van Broeckhoven C.V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum. Mol. Genet 2000, 9:325-331.
-
(2000)
Hum. Mol. Genet
, vol.9
, pp. 325-331
-
-
Theuns, J.1
Del-Favero, J.2
Dermaut, B.3
Van Duijn, C.M.4
Backhovens, H.5
Van Den Broeck, M.V.6
Serneels, S.7
Corsmit, E.8
Van Broeckhoven, C.V.9
Cruts, M.10
-
65
-
-
67649359888
-
Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin
-
Tippmann F., Hundt J., Schneider A., Endres K., Fahrenholz F. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 2009, 23:1643-1654.
-
(2009)
FASEB J.
, vol.23
, pp. 1643-1654
-
-
Tippmann, F.1
Hundt, J.2
Schneider, A.3
Endres, K.4
Fahrenholz, F.5
-
66
-
-
0042634362
-
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
-
Turner P.R., O'Connor K., Tate W.P., Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol 2003, 70:1-32.
-
(2003)
Prog. Neurobiol
, vol.70
, pp. 1-32
-
-
Turner, P.R.1
O'Connor, K.2
Tate, W.P.3
Abraham, W.C.4
-
67
-
-
0026572465
-
Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients
-
Van Nostrand W.E., Wagner S.L., Shankle W.R., Farrow J.S., Dick M., Rozemuller J.M., Kuiper M.A., Wolters E.C., Zimmerman J., Cotman C.W. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc. Natl. Acad. Sci. U S A 1992, 89:2551-2555.
-
(1992)
Proc. Natl. Acad. Sci. U S A
, vol.89
, pp. 2551-2555
-
-
Van Nostrand, W.E.1
Wagner, S.L.2
Shankle, W.R.3
Farrow, J.S.4
Dick, M.5
Rozemuller, J.M.6
Kuiper, M.A.7
Wolters, E.C.8
Zimmerman, J.9
Cotman, C.W.10
-
68
-
-
67649628753
-
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
-
Visser P.J., Verhey F., Knol D.L., Scheltens P., Wahlund L.O., Freund-Levi Y., Tsolaki M., Minthon L., Wallin A.K., Hampel H., Burger K., Pirttila T., Soininen H., Rikkert M.O., Verbeek M.M., Spiru L., Blennow K. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 2009, 8:619-627.
-
(2009)
Lancet Neurol
, vol.8
, pp. 619-627
-
-
Visser, P.J.1
Verhey, F.2
Knol, D.L.3
Scheltens, P.4
Wahlund, L.O.5
Freund-Levi, Y.6
Tsolaki, M.7
Minthon, L.8
Wallin, A.K.9
Hampel, H.10
Burger, K.11
Pirttila, T.12
Soininen, H.13
Rikkert, M.O.14
Verbeek, M.M.15
Spiru, L.16
Blennow, K.17
-
69
-
-
14844292105
-
Emerging prospects for the disease-modifying treatment of Alzheimer's disease
-
Walker L.C., Ibegbu C.C., Todd C.W., Robinson H.L., Jucker M., Levine H., Gandy S. Emerging prospects for the disease-modifying treatment of Alzheimer's disease. Biochem. Pharmacol 2005, 69:1001-1008.
-
(2005)
Biochem. Pharmacol
, vol.69
, pp. 1001-1008
-
-
Walker, L.C.1
Ibegbu, C.C.2
Todd, C.W.3
Robinson, H.L.4
Jucker, M.5
Levine, H.6
Gandy, S.7
-
70
-
-
29644432040
-
Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1
-
Watanabe N., Tomita T., Sato C., Kitamura T., Morohashi Y., Iwatsubo T. Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1. J. Biol. Chem 2005, 280:41967-41975.
-
(2005)
J. Biol. Chem
, vol.280
, pp. 41967-41975
-
-
Watanabe, N.1
Tomita, T.2
Sato, C.3
Kitamura, T.4
Morohashi, Y.5
Iwatsubo, T.6
-
71
-
-
47049087497
-
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects
-
Wu G., Sankaranarayanan S., Tugusheva K., Kahana J., Seabrook G., Shi X.P., King E., Devanarayan V., Cook J.J., Simon A.J. Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects. Clin. Biochem 2008, 41:986-996.
-
(2008)
Clin. Biochem
, vol.41
, pp. 986-996
-
-
Wu, G.1
Sankaranarayanan, S.2
Tugusheva, K.3
Kahana, J.4
Seabrook, G.5
Shi, X.P.6
King, E.7
Devanarayan, V.8
Cook, J.J.9
Simon, A.J.10
-
72
-
-
49449108546
-
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
-
Zetterberg H., Andreasson U., Hansson O., Wu G., Sankaranarayanan S., Andersson M.E., Buchhave P., Londos E., Umek R.M., Minthon L., Simon A.J., Blennow K. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch. Neurol 2008, 65:1102-1107.
-
(2008)
Arch. Neurol
, vol.65
, pp. 1102-1107
-
-
Zetterberg, H.1
Andreasson, U.2
Hansson, O.3
Wu, G.4
Sankaranarayanan, S.5
Andersson, M.E.6
Buchhave, P.7
Londos, E.8
Umek, R.M.9
Minthon, L.10
Simon, A.J.11
Blennow, K.12
-
73
-
-
42949119345
-
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
-
Zhang J., Sokal I., Peskind E.R., Quinn J.F., Jankovic J., Kenney C., Chung K.A., Millard S.P., Nutt J.G., Montine T.J. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am. J. Clin. Pathol 2008, 129:526-529.
-
(2008)
Am. J. Clin. Pathol
, vol.129
, pp. 526-529
-
-
Zhang, J.1
Sokal, I.2
Peskind, E.R.3
Quinn, J.F.4
Jankovic, J.5
Kenney, C.6
Chung, K.A.7
Millard, S.P.8
Nutt, J.G.9
Montine, T.J.10
-
74
-
-
20444472743
-
Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components
-
Zhang Y.W., Luo W.J., Wang H., Lin P., Vetrivel K.S., Liao F., Li F., Wong P.C., Farquhar M.G., Thinakaran G., Xu H. Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components. J. Biol. Chem 2005, 280:17020-17026.
-
(2005)
J. Biol. Chem
, vol.280
, pp. 17020-17026
-
-
Zhang, Y.W.1
Luo, W.J.2
Wang, H.3
Lin, P.4
Vetrivel, K.S.5
Liao, F.6
Li, F.7
Wong, P.C.8
Farquhar, M.G.9
Thinakaran, G.10
Xu, H.11
|